Cellbxhealth PLC
ANPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,862 | $2,186 | $1,041 | $1,013 |
| % Growth | 30.9% | 110% | 2.8% | – |
| Cost of Goods Sold | $1,083 | $2,594 | $428 | $302 |
| Gross Profit | $1,779 | -$408 | $613 | $711 |
| % Margin | 62.2% | -18.7% | 58.9% | 70.2% |
| R&D Expenses | $1,768 | $9,510 | $10,813 | $8,478 |
| G&A Expenses | $455 | $382 | $557 | $342 |
| SG&A Expenses | $455 | $382 | $557 | $342 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14,652 | $11,459 | $13,450 | $9,126 |
| Operating Expenses | $16,875 | $21,351 | $24,820 | $17,946 |
| Operating Income | -$15,096 | -$21,759 | -$24,207 | -$17,235 |
| % Margin | -527.5% | -995.4% | -2,325.4% | -1,701.4% |
| Other Income/Exp. Net | $67 | $127 | -$232 | -$128 |
| Pre-Tax Income | -$15,029 | -$21,632 | -$24,439 | -$17,363 |
| Tax Expense | -$804 | -$1,500 | -$2,753 | -$2,351 |
| Net Income | -$14,225 | -$20,132 | -$21,686 | -$15,012 |
| % Margin | -497% | -921% | -2,083.2% | -1,481.9% |
| EPS | -0.048 | -0.077 | -0.088 | -0.067 |
| % Growth | 37.6% | 12.1% | -31.8% | – |
| EPS Diluted | -0.048 | -0.077 | -0.088 | -0.067 |
| Weighted Avg Shares Out | 294,932 | 260,443 | 246,580 | 225,073 |
| Weighted Avg Shares Out Dil | 294,932 | 260,467 | 246,580 | 225,073 |
| Supplemental Information | – | – | – | – |
| Interest Income | $396 | $463 | $136 | $29 |
| Interest Expense | $307 | $325 | $354 | $157 |
| Depreciation & Amortization | $1,698 | $2,308 | $1,098 | $1,466 |
| EBITDA | -$13,024 | -$18,999 | -$24,387 | -$15,719 |
| % Margin | -455.1% | -869.1% | -2,342.7% | -1,551.7% |